Clinical Trials · NCT05780905
Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes
- Phase
- Phase 4
- Recruitment status
- Recruiting
- Sponsor
- University of Washington
- Enrollment
- 50
- Start date
- Jan 2024
- Locations
- 1 site, United States
- Primary endpoint
- Intracranial blood flow (IBF)